chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Prolonged dull pain in muscle between left shoulder and elbow as well as in muscle between elbow and wrist. Pain level 2-3 on a scale of 1 thru 10, with 10 being severe. Loss of strength in left dominant arm. Can't pick up a gallon of milk or water without use of other hand. Small lump under skin.
Patient got 2nd dose of Pfizer Covid vaccine on 08/17/2021. On Friday 08/20/2021 ~ 12:50pm, patient called to report that her right arm has been really hurt/painful for the last couple days and it has not gone away. She also reported that it's really painful that she can't lift it up without any difficulty. She said she took some Ibuprofen but didn't seem to help at all.
Moderna COVID-19 Vaccine   7 days after the injection - redness, soreness, swelling and hot to the touch near the vaccination site.  The redness spread over night to cover a large area on my upper arm.
Headache, Myalgia, Fever, NauseaVomiting, Fatigue, chills. Narrative:
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Joint Pain-Medium
one patient out of 12 pfizer first doses given received moderna vaccine and was documented as pfizer
My 9 year was at his doc for his 9 year check up and only got the flu shot on 11/4/19 later in the evening he said it hurt still. On 11/5/19 after school 3pm I checked his arm because he was complaining I notice it swollen red hard and hot I traced it. On 11/06/19 I was called by school nurse saying he was complaining. I spoke to his doc office and they advised allergic reaction and to check him out of school and give him Benadryl and keep eye on it. I checked my son out 11/06/19 approx 1230 and notice the red is past the first marking and I traced the new area
This spontaneous report was received from a registered pharmacist via a company representative refers to an approximately 60-year-old (reported as "in her 60s) female patient. On 16-APR-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date and route not reported). Approximately on an unknown date in April 2013, the patient developed an injection site reaction with a large area of redness which was swollen and warm. The patient was treated with an unspecified antibiotics for the events. It was unspecified whether lab diagnostic studies were performed for the event. The events resolved on an unknown date in April 2013. The patient sought medical attention by visiting the physician. Causality was not reported. Additional information has been requested.
Vaccinated on 10/31/06 with Tdap, flumist and Tb test. That night at home, she noted sore arm that got worse the next day. When she presented to the clinic on 11/2/06, there was swelling, erythema, pain and induration at injection site. This was causing some restriction of her ROM and tingling in hand/fingers.  Recommended OTC Ibuprofen and cold compress to injection site. Described severe allergic systemic reaction that would require emergent medical attention.
Developed muscle aches / getting worse; Feverish; This case was reported by a consumer via interactive digital media and described the occurrence of muscle pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th November 2020 09:30, the patient received the 2nd dose of Shingrix. On 18th November 2020 21:00, 11 hrs 30 min after receiving Shingrix, the patient experienced muscle pain and fever. On an unknown date, the outcome of the muscle pain and fever were unknown.   It was unknown if the reporter considered the muscle pain and fever to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient received second Shingrix vaccine at 9:30 am the patient was fine until about 9PM, when the patient developed muscle aches and feeling feverish (without a measurable fever).  The muscle aches were getting worse.
On 1/22/00, the pt developed more than 300 skin lesions which covered the pt's body and were also located on her eyelids. Unspecified medical attention was sought. It was noted that the second dose  of varicella was administered after the pt developed chickenpox. Additional information has been requested. Follow up states the patient recovered in early February.
Diffuse pruritic morbilliform rash noted on about 11/24/08, fairly impressive rash, looked like drug eruption.
extremely itchy rash, which began in the trunk of the body and spread to my entire body within a couple of days after appearing. Severe joint pain in knees, and wrists and fingers. All of these symptoms began about a week after the dose of MMR, which was administered on August 5, 2005
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was provided regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 29-JUL-2014, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the long-term prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On an unknown date in 2016, the patient was treated for the onset of a severe vesicular rash, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Rash to neck and left hand dorsum at digits 3,4 with mild edema and itching. Symptoms started about 24 hours moted to have rash on right side of neck that developed into two papules by the next day, 36 hours after vaccine started with rash to dorsum of right hand at digits 3,4 with mild edema at base of fingers.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Dec2022 at 16:45 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 43 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 30Apr2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 21May2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 27Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Paraseptal emphysema" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Mar2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Rebound after 2 days of testing negative. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical information: Other medication in 2weeks: Yes. The patient received Paxlovid from 05Mar2023 to 09Mar2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The reported COVID-19 after appropriately spaced doses of COVID-19 immunization is considered as vaccination failure of BNT162b2, BNT162b2 omi ba.4-5, and the Company cannot completely exclude the possible causality between the reported events and BNT162b2, BNT162b2 omi ba.4-5 administration.
pt recv vax & exp a fever for two days;pt devel more than 50 lesions on front & back of trunk & inside of mouth;pt seen by MD who described lesions as papular w/no vesicles, itching or scabs;dx mild case chickenpox;
intermittent episodes of subjective fever chills tachycardia nearly passing out headaches.  Symptoms started approximately 9 days ago after having a second maternal vaccine.  She states she is intermittently been feeling ill in terms of diffuse myalgias headaches today she had a racing heart rate and near syncope.  Denies any chest pain shortness of breath abdominal pain nausea vomiting diarrhea.
Pfizer COVID-19 Vaccine EUA Patient presented to ED for allergic reaction.  States that after getting her covid vaccine she developed diffuse pruritis, most notable in the hands.  States she had a "blotchy" rash on the face and chest.  No other associated symptoms including throat swelling, difficulty swallowing, wheezing, nausea, vomiting, CP, SOB, abdominal pain, diarrhea.  Has a history of previous reaction to the flu vaccine.  Given epi SQ at approximately 1015. States since administration she has had significant improvement. Also treated with diphenhydramine, prednisone, and famotidine.
The individual received the rabies vaccine series and rabies immunoglobulin as Rabies PEP to a stray cat bite.  The individual received the vaccines not according to the recommended intervals as well as received 2 additional rabies vaccine doses.
This spontaneous report was received from a medical assistant and refers to multiple patients of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On unknown dates, the patients were vaccinated with improperly stored PNEUMOVAX 23 lot # N011491 with expiry date: 04-NOV-2018 (dosing details, route and anatomical location were not reported) for prophylaxis. It was reported that the vaccines were exposed to a temperature range of 32 degree Fahrenheit to 35 degree Fahrenheit for a duration of 23 days. There was no previous temperature excursion. Data logger was involved. No adverse effects were reported. There were no product quality complaints (PQC) involved. Follow up information has been received from a medical assistant on 26-SEP-2017. The reporter stated that she had faxed the patient identifiers and dates of vaccination a month ago after she made the call. The medical assistant stated that she would refax them. Follow up information has been received on 04-OCT-2017. On 11-AUG-2017, a 73 years old patient of unknown gender was vaccinated with improperly stored PNEUMOVAX 23. This is one of 8 reports received from the same reporter. Sender's Comments: US-009507513-1708USA011337: US-009507513-1710USA008711: US-009507513-1710USA008713: US-009507513-1710USA008714: US-009507513-1710USA008715: US-009507513-1710USA008716: US-009507513-1710USA008717.
This spontaneous report as received from a pharmacist refers to a currently 71 year old female patient. The patient's concurrent condition included Crohn's disease. Her medical history was not reported. The patient has no drug reaction or allergies. On 04-JAN-2016 the patient was vaccinated with ZOSTAVAX (lot # L028281, expiry date: 28-OCT-2016) subcutaneously at a dose of 0.65 ml. Concomitant therapies included REMICADE (stopped 3 months back on an unknown date), probiotics (unspecified) and ASACOL. On an unknown date in January 2016 the patient experienced redness, itching and "a white spot, like a rash" after receiving ZOSTAVAX. On 07-JAN-2016 the patient sought medical attention from the pharmacist. She was treated with Over the Counter (OTC) BENADRYL for itching as needed. No lab diagnostics tests were performed. The outcome of redness, itching and "a white spot, like a rash" was reported as not recovered/not resolved. Causality assessment was not provided. Additional information has been requested.
After administering  the Hepatitis A vaccine and HPV vaccine, I was preparing to administer the MENVEO. But after administering the Hepatitis A and HPV vaccines client stated arm felt funny. Client then stated she needed to "throw up". Client vomited small amount in trash can. She then became very pale and began to lose consciousness. EMS was notified. She was moved onto the floor on her side to prevent aspiration. Vitals were taken. Blood pressure was 87/57, heart rate 74, SP02 98% room air. Pupils were dilated but when tested with pen light their response was equal and reactive to light. Client slowly became responsive. EMS took client's blood pressure while she was laying on the floor, sitting and then could not obtain one on her when she was standing. Client while sitting had twitches in lower extremities and stated she felt very cold. Client taken to hospital via EMS. MENVEO vaccine was wasted.
Cellulitis at site of vaccine injection. Improved with antibiotics. Acute illness made blood sugars increase.
arrhythmia; Heart palpitations; additional heartbeats 10% of the time during 5 days monitor; This is a spontaneous report from a contactable consumer (patient). A 47-year-old male patient received the first dose of bnt162b2, via an unspecified route of administration on 30Mar2021 11:30 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included Stage two kidney disease, LBBB, covid prior vaccination. Concomitant medication included metoprolol; atorvastatin. The patient experienced heart palpitations/arrhythmia did monitor for 10 days and had additional heartbeats 10% of the time during 5 days monitor. ECG and echo done and her monitor for 5 days. The events were occurred on 31Mar2021. The events resulted in Doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered.  Information on the Lot/Batch number has been requested.
Patient had swelling, redness, itching, blisters at injection site and some fever and pain.
1st shot a year ago, never got 2nd; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose a year ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the consumer. The age at vaccination was not applicable for this report. Till the time of reporting, the patient never get 2nd dose of Shingrix, which led to incomplete course of vaccination.
Child woke up with 10 cm of erythema and induration in right upper  thigh where shot given.  Entire upper thigh swollen.  Mild pruritis.  Child behaving normally.
This spontaneous report was received from a healthcare worker concerning unspecified number of patients of unknown age and gender. No concurrent conditions or medical history were reported. On an unknown date, unspecified number of patients were vaccinated with improperly stored doses of GARDASIL 9 (Lot # L007560 Expiration date: 15-JUN-2017). No adverse effect reported. No Product Quality Complaint (PQC) was involved. This is one of several repots received from the same source. Additional information has been requested.
Two days after shot I started getting canker sores in my mouth and on third day there were more.  Very painful and hard to eat food.  Went to clinic and he gave me Mylanta and told me to take.  It does seem a little better but still not gone.
bad body aches, muscle pain, Headache, fatigue, still ongoing, had 2 negative tests for COVID since onset of symptoms
I received the 2nd dose of my Hep A/B shot. The first time didn't hurt. the second time hurt so much when the needle went in that I yelled. 2 years later my arm still aches at the site. It doesn't hurt all of the time or keep me from doing normal things. It's just a reminder of the shot every time it aches. I didn't complete the 3rd dose because of the previous issue. I've had shots and vaccines before without issue.
Pt reported 7mo old son exp stomach & resp distress following administration of DPT/ORIMUNE; pt was seen in ER; no tx; pt also exp worsening of development problems; (related to CMV infect);
On February 7th at 11:00 at night I started throwing up and had a little diarrhea had stomach pain all through the night and at 6:00 the next morning February 8th I went to Paulding hospital where they said that I had a heart attack not sure if it was due to the covid shot that was given a couple weeks before since the hospital I have had different symptoms of numbness in the left two fingers and headaches and visual issues as well
has had numbness in her arm and now does not have any feeling down her entire left arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2023NVX-US-000001228 (Novavax).  A female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "has had numbness in her arm and now does not have any feeling down her entire left arm"; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization, reaction(s): "has had numbness in her arm and now does not have any feeling down her entire left arm". The following information was reported: HYPOAESTHESIA (non-serious), outcome "unknown", described as "has had numbness in her arm and now does not have any feeling down her entire left arm". Additional information:On 26Sep2023, it was reported that a patient (Age: 65, units not specified) started treatment on unreported date with Pfizer BioNTech COVID-19 vaccine primary series and booster for COVID-19 immunisation. It was reported that since her injections, the patient has had numbness in her arm and now does not have any feeling down her entire left arm. No further follow-up is anticipated  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300168693 Same patient/event, different dose;US-PFIZER INC-PV202300168694 Same patient/event, different dose;
Seriousness criteria other medically significant (OMIC). Initial report received from a physician on Oct 31 2005. A nine month old male infant developed extensive purpura on lower extremities and some on the face and ears three days after receiving the first injection of Fluzone, lot number U1743JA in the left thigh on Oct 25 2005. The patient has a history of eczema and is on topical steroid betamethasone. At the time of vaccination the patient had slight diarrhea. As per reporting physician the purpura resembles HSP Henoch Schonlein Purpura. The physician reports the mom stated the child had a low grade fever and has been fussy. At the time of this report the patient had not recovered. Follow-up information received on 15/Nov/2005 from a health care professional. It was reported that the FLUZONE was administered intra-muscularly. No investigations were completed for the diarrhea the patient had at the time of vaccination and the event resolved. The diagnosis of Henoch-Schonlein Purpura was not confirmed as per the reporter. The patient did not receive a subsequent dose of FLUZONE. The patient was seen by the physician on 11/Nov/2005 and was improved at that time. He has not been seen since and his recovery status is unknown. Follow-up information received on 16/Jan/2006 from a health care professional. Per the reporter, there have been no changes or further evaluation since 15/Nov/2005. The patient is well and has recovered.
Information has been received from a nurse a female who on an unspecified date was vaccinated with Gardasil (0.5 ml) (lot # 655503/0012U). It was reported that several days following vaccination the patient experienced a sharp, shooting pain at the injection site. Unspecified medical attention was sought. No further details were provided. At the time of this report, the patient had not recovered. Additional information has been requested. 07/06/07 This is in follow-up to report(s) previously submitted on 4/13/2007. Initial and follow-up information has been received from a nurse a 26 year old female with no pertinent medical history who on 28-FEB-2007 was vaccinated, into the left deltoid, with a first dose of GARDASIL (0.5 ml) (lot # 655503/0012U). On 28-FEB-2007, the patient experienced a sharp, shooting pain at the injection site. The patient called the physician's office on 14-MAR-2007 at 14:00. It was reported that the pain "comes and goes" and the pain is "worse than the injection". Subsequently, the patient recovered. No further information is available.
Information has been received from a nurse practitioner concerning a 20 year old female with no pertinent medical history and no history of drug reactions/allergies who on 03-APR-2008 was vaccinated with a first dose of GARDASIL (lot # 658219/0755U) 0.5 ml IM. There was no concomitant medication. On 03-APR-2008, within seconds of receiving the vaccination, the patient had a seizure and lost consciousness for 30 seconds. The patient was treated with oxygen. Her blood pressure was 95/56 and pulse 131. The patient was transported to a local emergency room via ambulance. The outcome of the events was not reported. The reporter felt that the seizure and loss of consciousness were immediately life-threatening and required intervention (Other Important Medical Events). Additional information has been requested.
pt recv vax 17JUL96 855AM & waited 5 min, pt faint & fell in front of cashier VS 80/38-72P-20-98;pt taken to exam room to lay down VS taken WNL;pt stated had not eaten anything since yesterday afternoon;denies any illness or allergy;
Fever; Nausea; Weakness; Stomach hurts/ stomach hurts worsened; Body aches/ body aches worsened; This is a spontaneous report from a contactable consumer (patient herself). A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 15Mar2021 (Batch/Lot Number: EN6205) as DOSE 1, SINGLE (age at vaccination was 53 years old) for covid-19 immunisation. Medical history included hypothyroidism from an unknown date and unknown if ongoing (Diagnosed 30 years ago). There were no concomitant medications. The patient was calling about the covid vaccine, she had the first dose on Monday with her husband. On 16Mar2021, the patient had body aches and reported her stomach hurted. On 17Mar2021, she experienced fever, nausea and weakness. The patient stated she felt cold, had body aches, a cough and was congested. Today the patient had a fever of 102.5 which she took acetaminophen for and it came down to 100.9. The patient also had body aches, her stomach hurted, she was nauseous and weak. The caller wanted to know if this was normal. Last night the patient was up all night coughing. This morning the patient couldn't get up off the bed. She took her temperature today, not last night, so she is unsure when the fever actually started. The body aches started last night. The caller felt very weak. She takes care of her daughter who is going through cancer. Body aches and Stomach hurts was reported as worsened. The patient underwent lab tests and procedures which included body temperature: 102.5 on 17Mar2021, body temperature: 100.9 on 17Mar2021. Therapeutic measures were taken as a result of fever (acetaminophen). The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.